Know Cancer’s Next Move: Using ctDNA to guide treatment decisions in patients with GI Cancer
This webinar will explore the expanding role of circulating tumor DNA (ctDNA) for assessing molecular residual disease (MRD) and monitoring treatment response in patients with colorectal cancer.